These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2106684

  • 1. Fractionation of heparin by chromatography on a tissue plasminogen activator-Sepharose column.
    Andrade-Gordon P, Strickland S.
    Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1865-9. PubMed ID: 2106684
    [Abstract] [Full Text] [Related]

  • 2. Anticoagulant low molecular weight heparin does not enhance the activation of plasminogen by tissue plasminogen activator.
    Andrade-Gordon P, Strickland S.
    J Biol Chem; 1989 Sep 15; 264(26):15177-81. PubMed ID: 2504719
    [Abstract] [Full Text] [Related]

  • 3. Localization of the binding sites of porcine tissue-type plasminogen activator and plasminogen to heparin.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Biochim Biophys Acta; 1987 Dec 18; 916(3):279-87. PubMed ID: 3120775
    [Abstract] [Full Text] [Related]

  • 4. Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.
    Horn IR, van den Berg BM, Moestrup SK, Pannekoek H, van Zonneveld AJ.
    Thromb Haemost; 1998 Nov 18; 80(5):822-8. PubMed ID: 9843178
    [Abstract] [Full Text] [Related]

  • 5. Low-affinity heparin stimulates the inactivation of plasminogen activator inhibitor-1 by thrombin.
    Patston PA, Schapira M.
    Blood; 1994 Aug 15; 84(4):1164-72. PubMed ID: 8049432
    [Abstract] [Full Text] [Related]

  • 6. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H, Fujimoto N, Sakurai K, Nagasawa K.
    J Chromatogr; 1984 Mar 30; 287(1):55-66. PubMed ID: 6725457
    [Abstract] [Full Text] [Related]

  • 7. Rapid and high-yield purification of porcine heart tissue-type plasminogen activator by heparin-sepharose choromatography.
    Soeda S, Kakiki M, Shimeno H, Nagamatsu A.
    Life Sci; 1986 Oct 13; 39(15):1317-24. PubMed ID: 3093793
    [Abstract] [Full Text] [Related]

  • 8. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW, Berry LR, Kaur H, Koj A, Regoeczi E.
    Can J Biochem; 1979 Oct 13; 57(10):1183-90. PubMed ID: 120212
    [No Abstract] [Full Text] [Related]

  • 9. An improved method for removal of antithrombin III from post-heparin plasma lipase fractions with a high recovery rate.
    Moriguchi EH, Tamachi H, Homma Y, Goto Y.
    Tokai J Exp Clin Med; 1991 Mar 13; 16(1):33-41. PubMed ID: 1780907
    [Abstract] [Full Text] [Related]

  • 10. Rational design of peptide ligand for affinity chromatography of tissue-type plasminogen activator by the combination of docking and molecular dynamics simulations.
    Liu FF, Dong XY, Wang T, Sun Y.
    J Chromatogr A; 2007 Dec 21; 1175(2):249-58. PubMed ID: 17996243
    [Abstract] [Full Text] [Related]

  • 11. Effects of different ions on the interactions of heparin with bovine antithrombin III and thrombin.
    Oshima G, Nagasawa K.
    Thromb Res; 1986 May 01; 42(3):375-82. PubMed ID: 3715809
    [Abstract] [Full Text] [Related]

  • 12. Heparin oligosaccharides enhance tissue-type plasminogen activator: a correlation between oligosaccharide length and stimulation of plasminogen activation.
    Edelberg JM, Conrad HE, Pizzo SV.
    Biochemistry; 1991 Nov 12; 30(45):10999-1003. PubMed ID: 1932024
    [Abstract] [Full Text] [Related]

  • 13. Binding of one-chain tissue-type plasminogen activator to fibrin, partially plasmin-degraded fibrin, lysine and heparin.
    Fischer B.
    Biomed Biochim Acta; 1991 Nov 12; 50(1):47-54. PubMed ID: 1830477
    [Abstract] [Full Text] [Related]

  • 14. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells.
    Hagège J, Delarue F, Peraldi MN, Sraer JD, Rondeau E.
    Lab Invest; 1994 Dec 12; 71(6):828-37. PubMed ID: 7807964
    [Abstract] [Full Text] [Related]

  • 15. Structural domains of human tissue-type plasminogen activator that confer stimulation by heparin.
    Stein PL, van Zonneveld AJ, Pannekoek H, Strickland S.
    J Biol Chem; 1989 Sep 15; 264(26):15441-4. PubMed ID: 2504721
    [Abstract] [Full Text] [Related]

  • 16. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N, Kikuchi M, Yosizawa Z.
    J Biochem; 1981 Jul 15; 90(1):241-6. PubMed ID: 7287679
    [Abstract] [Full Text] [Related]

  • 17. The composition of complexes between plasminogen activator inhibitor 1, vitronectin and either thrombin or tissue-type plasminogen activator.
    van Meijer M, Stoop A, Smilde A, Preissner KT, van Zonneveld AJ, Pannekoek H.
    Thromb Haemost; 1997 Mar 15; 77(3):516-21. PubMed ID: 9066004
    [Abstract] [Full Text] [Related]

  • 18. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE, Smith CJ.
    Arch Biochem Biophys; 1993 Nov 15; 307(1):138-45. PubMed ID: 8239651
    [Abstract] [Full Text] [Related]

  • 19. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A, Uchiyama H, Nagasawa K.
    Biochim Biophys Acta; 1980 Dec 16; 626(2):477-85. PubMed ID: 7213665
    [Abstract] [Full Text] [Related]

  • 20. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 16; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.